CA3072347C — Crystalline forms of compounds for preventing or treating sensory hair cell death
Assigned to University of Washington · Expires 2024-03-26 · 2y expired
What this patent protects
Provided herein is a crystalline form of a mesylate salt of (4R,75)-2-(3-(4-chlorophenyOureido)-9-methyl-5,6,7,8-tetrahydro-4H-4,7-epiminocyclohepta[b]thiophene-3-carboxamide, or solvate thereof wherein the mesylate salt has an X-ray powder diffraction (XRPD) pattern with charact…
USPTO Abstract
Provided herein is a crystalline form of a mesylate salt of (4R,75)-2-(3-(4-chlorophenyOureido)-9-methyl-5,6,7,8-tetrahydro-4H-4,7-epiminocyclohepta[b]thiophene-3-carboxamide, or solvate thereof wherein the mesylate salt has an X-ray powder diffraction (XRPD) pattern with characteristic peaks at 7.6 2-Theta, 10.6 2-Theta, 15.0 2-Theta, 16.0 2-Theta, 16.8 2-Theta, 17.7 2-Theta, 21.9 2-Theta, and 22.5 2-Theta. Further there are provided pharmaceutical compositions comprising the crystalline form and uses thereof.
Drugs covered by this patent
- Klisyri (TIRBANIBULIN) · Almirall
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.